← AEHR 研究档案

AEHR · Valuation DR

深潜研究原文 · 永久存档,不回改

AEHR — Phase 1.5 Pre-cryst Valuation DR

Generated: 2026-08-04T04:19:49Z
Round: 4 | research_version: 1
Source: Claude Code CLI (dr_dispatcher, phase=phase1_5_valuation)
Independence: xbrl_context=None (ADR-0034 §4.2)


AEHR (Aehr Test Systems) — Pre-crystallization 独立估值

一、Segment 识别

从三轮 Phase 1 研究材料看,AEHR 表面上是一家单一业务公司(半导体 burn-in 测试设备),但其 FY2026-FY2027 的收入构成、客户驱动力、竞争格局、周期位置在四个终端市场之间差异极大——用单一 multiple 估值会掩盖内部的巨大对冲效应。因此我按终端应用市场(而非按产品线 FOX-XP vs. Sonoma)拆分为 4 个 segment 独立估值:

  1. AI Processor Burn-In(主体为 Sonoma PPBI + FOX-XP WLBI AI 评估路径)
  2. Silicon Photonics WLBI(FOX-XP + WaferPak,服务数据中心光互联)
  3. SiC/GaN Power Semiconductor(FOX-XP + WaferPak,深度周期)
  4. Optionality(Memory NAND/HBM + Silicon MOSFET + 未来客户扩展)

以及企业级的 Net cash 调整(现金 $116.5M,零债务)。

二、每个 Segment 的估值方法与关键数字

Segment 1: AI Processor Burn-In

这是估值中最难的一块,因为 FY2027 该 segment 收入约 $91-105M(占指引 ~70%),但单一超大规模云厂商贡献 40-70%——既是最大增长引擎,也是最大 concentration risk。竞争格局也在剧变:AEM Holdings AMPS-BI 已获得至少一家 AI/HPC 客户的 Plan-of-Record,双寡头雏形已现。

我用归一化盈利 × P/E multiple方法,而非纯 EV/Sales,因为公司显示了明确的经营杠杆路径(Q4 FY2026 non-GAAP GM 已回升至 45%):

Bear 到 Bull 差 20 倍——差异来自三个变量:单一 hyperscaler 是否续单、第二 hyperscaler 是否量产、AEM 竞争压力下的定价维持能力。

Segment 2: Silicon Photonics WLBI

这个 segment 在我看来是研究材料中最被低估的一块。理由:AEHR 是 SiPh WLBI 环节目前唯一已知量产级供应商(三支柱格局中 AEHR 与 FormFactor、Keysight 不构成直接竞争);1.6T 收发器进入量产(预计 2026 年底 Google/AWS)将触发新一代 WaferPak 订单波;已有 2 家确认客户 + 第 3 家初始订单。FY2027 收入约 $20-30M,但增长率明显。

方法:revenue multiple + 隐含 NOPAT 交叉验证(因为增长率高、盈利尚未完全释放):

Segment 3: SiC/GaN Power Semiconductor

深度周期、正在触底。FY2023 峰值时占公司收入 60%+,FY2026 骤降至 <5%。Yole 预测 SiC capex 2027-2028 触底。但 2026 年 7 月 $8M WaferPak 订单 + Q4 FY2026 Contactors 环比 +93% 是初步复苏信号。8 英寸迁移是明确的中期催化剂(WaferPak 定制化重启)。GaN 有 12+ WaferPak 设计在 sampling。

关键判断:这是耗材飞轮驱动的 segment,即便系统订单低迷,随着安装基础的 8 英寸升级和 GaN 加入,WaferPak 消耗性收入应逐步恢复。

方法:归一化 through-cycle 收入 × EV/Sales(考虑周期性给略低 multiple):

Segment 4: Optionality(Memory / MOSFET / Wafer-level AI)

管理层明确将这些排除在 FY2027 指引之外,性质为纯 real option
- HBM4E embedded BIST 标准可能为 AEHR 打开 memory 市场(管理层追了十年)
- Silicon MOSFET 首客已签
- FOX-XP 晶圆级 AI processor 评估"超出预期",客户进入试产验证

方法:scenario-weighted real option value——不是 DCF,因为这些业务当前收入为零:

企业级调整

三、企业级汇总

Segment Bear ($B) Base ($B) Bull ($B)
AI Processor Burn-In 0.10 0.55 2.00
Silicon Photonics WLBI 0.08 0.275 0.50
SiC/GaN Power Semi 0.045 0.20 0.40
Optionality 0.00 0.075 0.40
Net cash 0.12 0.12 0.12
Total 0.345 1.22 3.42

Bear 到 Bull 约 10 倍差距——这个 spread 反映了 AEHR 作为高度未来依赖型 story stock 的真实不确定性:如果 hyperscaler 客户按承诺履约、SiC 如期复苏、Memory 兑现,公司可能是下一个 semi cap 增长标的;若 hyperscaler 客户变心、SiC 继续低迷、Memory 再次跳票,公司回落至 low-scale 现金型公司。

四、Bull / Base / Bear 差异化逻辑

五、Anti-anchoring 显式声明

Phase 1 R3 中出现了以下 anchor 数据,我刻意跳过
1. Analyst target prices(Lake Street $110、Craig-Hallum $125、Freedom $110)——完全没用于 back-solve
2. "Q4 FY2026 earnings 当日股价跳涨约 40%"——刻意不推断绝对市值
3. FY2027 non-GAAP pretax margin 指引 18-22% —— 用作 sanity check but 不作为唯一的估值 anchor(我用了自己的 through-cycle margin assumption)

我的 total_base_b = $1.22B 是自下而上的 segment 加总,不是"贴近现价"倒推。

六、我 deliberately 没做的事

七、关键假设(可证伪点)

见 JSON key_assumptions

{
  "schema_version": 1,
  "ticker": "AEHR",
  "produced_at": "2026-08-04T04:15:00Z",
  "total_bull_b": 3.42,
  "total_base_b": 1.22,
  "total_bear_b": 0.345,
  "epistemic_tag": "EST",
  "segments": [
    {
      "segment_name": "AI Processor Burn-In (Sonoma PPBI + FOX-XP WLBI)",
      "methodology": "Normalized NOPAT × P/E multiple, scenario-based",
      "bull_b": 2.0,
      "base_b": 0.55,
      "bear_b": 0.10,
      "narrative": "Base: FY2028-2029 revenue $180M (Sonoma steady $150M + second hyperscaler $30M), 20% operating margin, 20x P/E. Bull: full $500M TAM capture per management, 25% op margin, 22x. Bear: single hyperscaler churn, revenue drops to $50M steady-state, 15-20x on depressed earnings."
    },
    {
      "segment_name": "Silicon Photonics WLBI",
      "methodology": "EV/Sales with NOPAT cross-check",
      "bull_b": 0.50,
      "base_b": 0.275,
      "bear_b": 0.08,
      "narrative": "Base: FY2028-2029 revenue $50M at 6x EV/Sales (essentially monopoly position in SiPh WLBI). Bull: 1.6T transceiver + CPO adoption drives $100M steady-state. Bear: only 2 customers stall at combined $20M."
    },
    {
      "segment_name": "SiC/GaN Power Semiconductor WLBI + WaferPak",
      "methodology": "Through-cycle revenue × EV/Sales",
      "bull_b": 0.40,
      "base_b": 0.20,
      "bear_b": 0.045,
      "narrative": "Base: FY2028 recovery to $50M normalized (8-inch WaferPak + early GaN + partial system orders) × 5x. Bull: full recovery to $80M including GaN volume. Bear: Yole trough extends to FY2029+, WaferPak stays depressed at $15M."
    },
    {
      "segment_name": "Optionality (Memory / Silicon MOSFET / Wafer-level AI processor)",
      "methodology": "Scenario-weighted real option value",
      "bull_b": 0.40,
      "base_b": 0.075,
      "bear_b": 0.0,
      "narrative": "Explicitly excluded from FY2027 guidance. Base: modest option value on Memory + wafer-level AI conversion. Bull: HBM4E BIST opens Memory market + wafer-level AI processor becomes new major line, comparable to Sonoma. Bear: 10+ years chasing Memory suggests skepticism, assign zero."
    },
    {
      "segment_name": "Net cash adjustment",
      "methodology": "Balance sheet",
      "bull_b": 0.12,
      "base_b": 0.12,
      "bear_b": 0.12,
      "narrative": "$116.5M cash, zero debt as of FY2026 Q4 post-ATM raise. ~$0.12B net cash added to all scenarios."
    }
  ],
  "key_assumptions": [
    "Single hyperscale AI customer (unidentified) continues Sonoma orders beyond current $41M backlog into FY2028+, not switching to AEM AMPS-BI; base assumes ~$100-150M steady-state contribution from this customer",
    "Silicon Photonics achieves 2-3 additional customers by FY2028 as 1.6T optical transceivers scale, and AEHR retains monopoly-adjacent position in SiPh WLBI",
    "SiC through-cycle normalized revenue of $50M+ is achievable by FY2028 despite Yole's 2027-2028 trough forecast, driven by 8-inch WaferPak refresh and GaN convergence",
    "FY2027 non-GAAP operating margin reaches 15-20% (implied by 18-22% pretax margin guidance) and sustains, giving base-case operating leverage without further dilutive raises",
    "Export control risk (ECCN 3B002 undisclosed) does not lead to material BIS license denial for FOX-XP systems or WaferPak consumables to China-adjacent customers over the FY2027-FY2029 horizon",
    "No further meaningful equity dilution beyond current ~33M diluted share count; ATM program largely completed",
    "Memory business remains an unproven optionality that neither confirms into base guidance nor completely disappears — modest real option value in base case"
  ]
}